跳至主要内容
临床试验/IRCT201407078129N7
IRCT201407078129N7已完成未知

Evaluation of efficacy of Resveratrol on hypertension, a randomized cross-over double- blinded placebo-controlled trial

Deputy of Research, Bushehr University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Pre-hypertensive(average of two times measurement with an interval of 15 minutes, diastolic and systolic blood pressure(80-89mmHg, 120-139 mmHg respectively)
  • Stage 1 hypertensive (average of two times measurement with an interval of 15 minutes (diastolic and systolic blood pressure 90-99 mmHg, 140-159 mmHg, respectively)
  • Male or Female
  • Age between 20 and 60-years
  • Ability to provide informed consent

排除标准

  • Approved or doubtful secondary hypertension; History of chronic or acute kidney Disease; History of heart failure; History of chronic or acute liver diseases; History of diabetes mellitus; History of prior cardiovascular events (Acute Myocardial Infarction, Cardiovascular diseases, Percutaneous Coronary Angioplasty or Coronary Artery Bypass Graft); Pregnancy or breast feeding;Blood arterial pressure >160/110

研究者

发起方
Deputy of Research, Bushehr University of Medical Sciences

相似试验